Dapsone-induced methemoglobinemia: A primer for clinicians;Metahemoglobinemia inducida por dapsona: Un manual para facultativos

Annals of Pharmacotherapy

Volumn 45, Issue 9, 2011, Pages 1103-1115

  Barclay, James A ^a   Ziemba, Stamatina E ^b   Ibrahim, Rami B ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b Michigan State University ^*  (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Dapsone; Methemoglobin; Methemoglobinemia; Methylene blue

Indexed keywords

ACTIVATED CARBON; ASCORBIC ACID; CHARCOAL; CIMETIDINE; CLOMIPRAMINE; DAPSONE; DULOXETINE; METHEMOGLOBIN; METHYLENE BLUE; SULFAMETHOXAZOLE; VENLAFAXINE;

ANEMIA; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CYANOSIS; DIAPHORESIS; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DYSPNEA; ECG ABNORMALITY; FECES DISCOLORATION; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; HYPOGLYCEMIA; HYPOTENSION; LEPROSY; METHEMOGLOBINEMIA; NAUSEA; ORAL DYSESTHESIA; PEMPHIGUS; PNEUMONIA; PRIORITY JOURNAL; SEROTONIN SYNDROME; SIDE EFFECT; SKIN DISCOLORATION; SYMPTOM; T WAVE INVERSION; THORAX PAIN; THROMBOCYTOPENIA; URINE DISCOLORATION;

ANEMIA, HEMOLYTIC; ANTI-INFECTIVE AGENTS; DAPSONE; ENZYME INHIBITORS; HUMANS; METHEMOGLOBINEMIA; METHYLENE BLUE; RISK FACTORS; TREATMENT OUTCOME;

EID: 80052432608     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q139     Document Type: Article

References (66)

1. Sangiolo D, Storer B, Nash R, et al. Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study. Biol Blood Marrow Transplant 2005;11:521-9. DOI 10.1016/j.bbmt.2005.04.011
2. Ward KE, McCarthy MW. Dapsone-induced methemoglobinemia. Ann Pharmacother 1998;32:549-53. DOI 10.1345/aph.17003
3. Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev 2004;17:770-82. DOI 10.1128/CMR.17.4.770-782.2004
4. Erstad BL. Dapsone-induced methemoglobinemia and hemolytic anemia. Clin Pharm 1992;11:800-5.
5. Naik PM, Lyon GM 3rd, Ramirez A, et al. Dapsone-induced hemolytic anemia in lung allograft recipients. J Heart Lung Transplant 2008;27: 1198-202. DOI 10.1016/j.healun.2008.07.025
6. Vasconcelles MJ, Bernardo MV, King C, Weller EA, Antin JH. Aero-solized pentamidine as Pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. Biol Blood Marrow Transplant 2000;6:35-43.
7. Hughes WT. Use of dapsone in the prevention and treatment of Pneumo-cystis carinii pneumonia: a review. Clin Infect Dis 1998;27:191-204.
8. Dunford LM, Roy DM, Hahn TE, et al. Dapsone-induced methe-moglobinemia after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006;12:241-2. DOI 10.1016/j.bbmt.2005.10.008
9. Coleman MD, Coleman NA. Drug-induced methaemoglobinaemia. Treatment issues. Drug Saf 1996;14:394-405.
10. Plotkin JS, Buell JF, Njoku MJ, et al. Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. Liver Transpl Surg 1997;3:149-52.
11. Walker JG, Kadia T, Brown L, Juneja HS, de Groot JF. Dapsone induced methemoglobinemia in a patient with glioblastoma. J Neurooncol 2009; 94:149-52. DOI 10.1007/s11060-009-9813-8
12. Zosel A, Rychter K, Leikin JB. Dapsone-induced methemoglobinemia: case report and literature review. Am J Ther 2007;14:585-7. DOI 10.1097/MJT.0b013e3180a6af55
13. Pallais JC, Mackool BT, Pitman MB. Case records of the Massachusetts General Hospital: Case 7-2011: a 52-year-old man with upper respiratory symptoms and low oxygen saturation levels. N Engl J Med 2011; 364:957-66. DOI 10.1056/NEJMcpc1013923
14. Fitzsimons MG, Gaudette RR, Hurford WE. Critical rebound methemoglobinemia after methylene blue treatment: case report. Pharmacotherapy 2004;24:538-40.
15. Hansen DG, Challoner KR, Smith DE. Dapsone intoxication: two case reports. J Emerg Med 1994;12:347-51.
16. Turner MD, Karlis V, Glickman RS. The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report. Anesth Prog 2007;54:115-7. DOI 10.2344/0003-3006(2007)54[115:TRPATO]2.0.CO;2
17. Caudill L, Walbridge J, Kuhn G. Methemoglobinemia as a cause of coma. Ann Emerg Med 1990;19:677-9.
18. Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore) 2004;83:265-73.
19. Mehta M. Cimetidine and dapsone-mediated methaemoglobinaemia. Anaesthesia 2007;62:1188. DOI 10.1111/j.1365-2044.2007.05332.x
20. Craig D, Cadden IS, Gormley WP, Riley MS, Jones FG, McMullin MF. Dapsone-induced methhaemoglobinaemia: a source of diagnostic confusion. Int J Clin Pract 2000;54:194-6.
21. Falkenhahn M, Kannan S, O'Kane M. Unexplained acute severe methaemoglobinaemia in a young adult. Br J Anaesth 2001;86:278-80.
22. O'Dwyer D, McElvaney NG. A case of dapsone induced methaemoglobinaemia. Ir J Med Sci 2008;177:273-5. DOI 10.1007/s11845-008-0176-5
23. Choi A, Sarang A. Drug-induced methaemoglobinaemia following elective coronary artery bypass grafting. Anaesthesia 2007;62:737-40. DOI 10.1111/j.1365-2044.2007.05000.x
24. Thunga G, Sam KG, Patel D, et al. Effectiveness of hemodialysis in acute dapsone overdose-a case report. Am J Emerg Med 2008;26:1070 e1-4. DOI 10.1016/j.ajem.2008.03.031
25. Berlin G, Brodin B, Hilden JO, Martensson J. Acute dapsone intoxication: a case treated with continuous infusion of methylene blue, forced diuresis and plasma exchange. J Toxicol Clin Toxicol 1984;22:537-48. DOI 10.1016/S0009-9236(99)90081-4
26. Williams S, MacDonald P, Hoyer JD, Barr RD, Athale UH. Methemoglobinemia in children with acute lymphoblastic leukemia (ALL) receiving dapsone for Pneumocystis carinii pneumonia (PCP) prophylaxis: a correlation with cytochrome b5 reductase (Cb5R) enzyme levels. Pediatr Blood Cancer 2005;44:55-62. DOI 10.1002/pbc.20164
27. Prasad R, Singh R, Mishra OP, Pandey M. Dapsone induced methemoglobinemia: intermittent vs continuous intravenous methylene blue therapy. Indian J Pediatr 2008;75:245-7.
28. Coleman MD, Rhodes LE, Scott AK, et al. The use of cimetidine to reduce dapsone dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br J Clin Pharmacol 1992;34:244-9.
29. Bluhm RE, Adedoyin A, McCarver DG, Branch RA. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors. Clin Pharmacol Ther 1999;65:598-605. DOI 10.1016/S0009-9236(99)90081-4
30. Rhodes LE, Tingle MD, Park BK, Chu P, Verbov JL, Friedmann PS. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol 1995;132:257-62.
31. Abouraya M, Sacco JC, Hayes K, Thomas S, Kitchens CS, Trepanier LA. Dapsone associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity. J Clin Pharmacol Epub 21 March 2011. DOI 10.1177/0091270010393343
32. Ganesan S, Sahu R, Walker LA, Tekwani BL. Cytochrome P450 - dependent toxicity of dapsone in human erythrocytes. J Appl Toxicol 2010;30:271-5. DOI 10.1002/jat.1493
33. Coleman MD, Jacobus DP. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro-II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma. Biochem Pharmacol 1993;46:1363-8.
34. Lee I, Barton TD, Goral S, et al. Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients. Am J Transplant 2005;5:2791-5.
35. Talarico JF, Metro DG. Presentation of dapsone-induced methemoglobinemia in a patient status post small bowel transplant. J Clin Anesth 2005;17:568-70. DOI 10.1016/j.jclinane.2004.10.011
36. Clifton J 2nd, Leikin JB. Methylene blue. Am J Ther 2003;10:289-91.
37. Paciullo CA, McMahon Horner D, Hatton KW, Flynn JD. Methylene blue for the treatment of septic shock. Pharmacotherapy 2010;30:702-15. DOI 10.1592/phco.30.7.702
38. Ng BK, Cameron AJ. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics 2010;51:194-200. DOI 10.1176/appi.psy.51.3.194
39. Ferguson AJ, Lavery GG. Deliberate self-poisoning with dapsone. A case report and summary of relevant pharmacology and treatment. Anaesthesia 1997;52:359-63.
40. Andrzejowski J. Dapsone methaemoglobinaemia. Anaesth Intensive Care 1998;26:117-8.
41. Bucaretchi F, Miglioli L, Baracat EC, Madureira PR, Capitani EM, Vieira RJ. [Acute dapsone exposure and methemoglobinemia in children: treatment with multiple doses of activated charcoal with or without the administration of methylene blue]. J Pediatr (Rio J) 2000;76:290-4.
42. Southgate HJ, Masterson R. Lessons to be learned: a case study approach: prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; treatment with methylene blue and exchange transfusion. J R Soc Promot Health 1999;119:52-5.
43. Narayanan N, Conlon N, Seigne P. Acute methaemoglobinaemia secondary to intentional dapsone overdose. Ir Med J 2010;103:285.
44. Shadnia S, Rahimi M, Moeinsadat M, Vesal G, Donyavi M, Abdollahi M. Acute methemoglobinemia following attempted suicide by Dapson. Arch Med Res 2006;37:410-4. DOI 10.1016/j.arcmed.2005.06.010
45. Park KH, Kim H, Lee CC, et al. Dapsone intoxication: clinical course and characteristics. Clin Toxicol (Phila) 2010;48:516-21. DOI 10.3109/15563650.2010.490534
46. Carrazza MZ, Carrazza FR, Oga S. Clinical and laboratory parameters in dapsone acute intoxication. Rev Saude Publica 2000;34:396-401.
47. Goolamali SI, Macfarlane CS. The use of cimetidine to reduce dapsonedependent haematological side-effects in a patient with mucous membrane pemphigoid. Clin Exp Dermatol 2009;34:e1025-6. DOI 10.1111/j.1365-2230.2009.03710.x
48. Alapat PM, Zimmerman JL. Toxicology in the critical care unit. Chest 2008;133:1006-13. DOI 10.1378/chest.07-1840
49. Arrivabene Caruy CA, Cardoso AR, Cespedes Paes F, Ramalho Costa L. Perioperative methemoglobinemia. Minerva Anestesiol 2007;73:377-9.
50. McIntosh K, Cooper E, Xu J, et al. Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group. Pediatr Infect Dis J 1999; 18:432-9.
51. Pavri RS, Gupta AD, Baxi AJ, Advani SH. Further evidence for oxidative damage to hemoglobin and red cell membrane in leukemia. Leuk Res 1983;7:729-33.
52. Reilly TP, Woster PM, Svensson CK. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions. J Pharmacol Exp Ther 1999; 288:951-9.
53. Esbenshade AJ, Ho RH, Shintani A, Zhao Z, Smith LA, Friedman DL. Dapsone-induced methemoglobinemia: a dose-related occurrence? Cancer 2011;117(15):3485-92. DOI 10.1002/cncr.25904
54. Abidi MH, Kozlowski JR, Ibrahim RB, Peres E. The sulfone syndrome secondary to dapsone prophylaxis in a patient undergoing unrelated hematopoietic stem cell transplantation. Hematol Oncol 2006;24:164-5. DOI 10.1002/hon.780
55. Vieira JL, Riveira JG, Martins Ade N, Silva JP, Salgado CG. Methe-moglobinemia and dapsone levels in patients with leprosy. Braz J Infect Dis 2010;14:319-21.
56. Mandrell BN, McCormick JN. Dapsone-induced methemoglobinemia in pediatric oncology patients: case examples. J Pediatr Oncol Nurs 2001; 18:224-8. DOI 10.1053/jpon.2001.26876
57. Salamat A, Watson HG. Drug-induced methaemoglobinaemia presenting with angina following the use of dapsone. Clin Lab Haematol 2003; 25:327-8.
58. Schiff DE, Roberts WD, Sue YJ. Methemoglobinemia associated with dapsone therapy in a child with pneumonia and chronic immune throm-bocytopenic purpura. J Pediatr Hematol Oncol 2006;28:395-8.
59. Moulis G, Bagheri H, Saint Martory J, Bernard P, Montastruc JL. Very late relapse of dapsone-induced methaemoglobinemia. Eur J Clin Pharmacol 2010;66:645-6. DOI 10.1007/s00228-010-0801-x
60. Subramaniam A, Corallo C, Nagappan R. Dapsone-associated methaemo-globinaemia in patients with a haematologic malignancy. Anaesth Intensive Care 2010;38:1070-6.
61. Ashurst JV, Wasson MN, Hauger W, Fritz WT. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia. J Am Osteopath Assoc 2010;110:16-20.
62. Cho SS, Park YD, Noh JH, Kang KO, Jun HJ, Yoon JS. Anesthetic experience of methemoglobinemia detected during general anesthesia for gas-trectomy of advanced gastric cancer-a case report. Korean J Anesthesiol 2010;59:340-3. DOI 10.4097/kjae.2010.59.5.340
63. Zelenitsky SA, Zhanel GG. Phenazopyridine in urinary tract infections. Ann Pharmacother 1996;30:866-8.
64. Bozzette SA, Finkelstein DM, Spector SA, et al. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection NIAID AIDS Clinical Trials Group. N Engl J Med 1995;332:693-9. DOI 10.1056/NEJM199503163321101
65. Souza JP, Boeckh M, Gooley TA, Flowers ME, Crawford SW. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin Infect Dis 1999;29:1467-71. DOI 10.1086/313509
66. Maltezou HC, Petropoulos D, Choroszy M, et al. Dapsone for Pneumo-cystis carinii prophylaxis in children undergoing bone marrow transplantation. Bone Marrow Transplant 1997;20:879-81. DOI 10.1038/sj.bmt.1700978